-
Something wrong with this record ?
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)
B. Stiburkova, K. Pavelcova, L. Petru, J. Krijt,
Language English Country United States
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Aldehyde Oxidase deficiency genetics MeSH
- Adult MeSH
- Uric Acid blood MeSH
- Humans MeSH
- Mercaptopurine adverse effects analogs & derivatives metabolism MeSH
- Methyltransferases genetics MeSH
- Polymorphism, Genetic genetics MeSH
- Purine-Pyrimidine Metabolism, Inborn Errors genetics MeSH
- Sulfurtransferases genetics MeSH
- Xanthine urine MeSH
- Xanthine Dehydrogenase deficiency genetics MeSH
- Xanthine Oxidase genetics MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The aim of our study was to identify the genetic background of thiopurine-induced toxicity in a patient with a wild-type thiopurine methyltransferase genotype and activity. A 38-year-old Caucasian woman presented with cutaneous necrotizing vasculitis pancytopenia one month after starting azathioprine therapy. METHODS: During a routine biochemical follow-up of the patient, undetectable serum uric acid (<10 μl) was observed. A high performance liquid chromatography analysis of urinary purines revealed increased levels of xanthine (137 mmol/mol creatinine). The suspected diagnosis of hereditary xanthinuria, a rare autosomal recessive disorder of the last two steps of purine metabolism, was confirmed by sequence analysis. RESULTS: An analysis of XDH/XO and AOX1 revealed common polymorphisms, while analysis of the MOCOS gene identified a rare homozygous variant c.362C > T. Dysfunction of this variant was confirmed by significantly decreased xanthine dehydrogenase/oxidase activity in the patient's plasma (<2% of control mean activity). CONCLUSIONS: We present a biochemical, enzymatic, and molecular genetic case study suggesting an important association between a hitherto undescribed dysfunction variant in the MOCOS gene and thiopurine-induced toxicity. The identified variant c.362C > T results in slower thiopurine metabolism caused by inhibition of 6-mercaptopurine oxidation (catabolism) to 6-thioxanthine and 6-thiouric acid, which increases the formation of the nucleotide 6-thioguanine, which is toxic. This is the first clinical case to identify the crucial role of the MOCOS gene in thiopurine intolerance and confirm the impact of genetic variability of purine enzymes on different therapeutic outcomes in patients undergoing thiopurine treatment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028355
- 003
- CZ-PrNML
- 005
- 20190816124350.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.taap.2018.06.015 $2 doi
- 035 __
- $a (PubMed)29935280
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stiburkova, Blanka $u Institute of Rheumatology, Prague, Czech Republic; Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic. Electronic address: stiburkova@revma.cz.
- 245 10
- $a Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II) / $c B. Stiburkova, K. Pavelcova, L. Petru, J. Krijt,
- 520 9_
- $a BACKGROUND: The aim of our study was to identify the genetic background of thiopurine-induced toxicity in a patient with a wild-type thiopurine methyltransferase genotype and activity. A 38-year-old Caucasian woman presented with cutaneous necrotizing vasculitis pancytopenia one month after starting azathioprine therapy. METHODS: During a routine biochemical follow-up of the patient, undetectable serum uric acid (<10 μl) was observed. A high performance liquid chromatography analysis of urinary purines revealed increased levels of xanthine (137 mmol/mol creatinine). The suspected diagnosis of hereditary xanthinuria, a rare autosomal recessive disorder of the last two steps of purine metabolism, was confirmed by sequence analysis. RESULTS: An analysis of XDH/XO and AOX1 revealed common polymorphisms, while analysis of the MOCOS gene identified a rare homozygous variant c.362C > T. Dysfunction of this variant was confirmed by significantly decreased xanthine dehydrogenase/oxidase activity in the patient's plasma (<2% of control mean activity). CONCLUSIONS: We present a biochemical, enzymatic, and molecular genetic case study suggesting an important association between a hitherto undescribed dysfunction variant in the MOCOS gene and thiopurine-induced toxicity. The identified variant c.362C > T results in slower thiopurine metabolism caused by inhibition of 6-mercaptopurine oxidation (catabolism) to 6-thioxanthine and 6-thiouric acid, which increases the formation of the nucleotide 6-thioguanine, which is toxic. This is the first clinical case to identify the crucial role of the MOCOS gene in thiopurine intolerance and confirm the impact of genetic variability of purine enzymes on different therapeutic outcomes in patients undergoing thiopurine treatment.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a aldehydoxidasa $x nedostatek $x genetika $7 D042931
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a merkaptopurin $x škodlivé účinky $x analogy a deriváty $x metabolismus $7 D015122
- 650 _2
- $a methyltransferasy $x genetika $7 D008780
- 650 _2
- $a polymorfismus genetický $x genetika $7 D011110
- 650 _2
- $a poruchy metabolismu purinů a pyrimidinů $x genetika $7 D011686
- 650 _2
- $a sulfurtransferasy $x genetika $7 D013466
- 650 _2
- $a kyselina močová $x krev $7 D014527
- 650 _2
- $a xanthin $x moč $7 D019820
- 650 _2
- $a xanthindehydrogenasa $x nedostatek $x genetika $7 D014968
- 650 _2
- $a xanthinoxidasa $x genetika $7 D014969
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pavelcova, Katerina $u Institute of Rheumatology, Prague, Czech Republic; Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Petru, Lenka $u Institute of Rheumatology, Prague, Czech Republic; Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Krijt, Jakub $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00010691 $t Toxicology and applied pharmacology $x 1096-0333 $g Roč. 353, č. - (2018), s. 102-108
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29935280 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816124620 $b ABA008
- 999 __
- $a ok $b bmc $g 1433504 $s 1066815
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 353 $c - $d 102-108 $e 20180620 $i 1096-0333 $m Toxicology and applied pharmacology $n Toxicol Appl Pharmacol $x MED00010691
- LZP __
- $a Pubmed-20190813